1-2 of 2
Gabriel Carvalho Pereira
Close
Sort by
Journal Articles

Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America

Renato L Guerino-Cunha, Diego Clé, Leonardo Carvalho Palma, Camila Dermínio Donadel, Lucas Oliveira, Patricia Oliveira da Cunha Terra, Thalita Cristina de Mello Costa, Juliana Bernardes Elias Dias, Fabiano Pieroni, Ana Beatriz Pereira Lima Stracieri, Caio Raony Farina Silveira, Marcelo Lourencini Puga, Amanda Mizukami Martins, Sâmia Rigotto Caruso, Lucas Eduardo Botelho Souza, Daianne Maciely Carvalho Fantacini, Leticia Maria Defendi Barboza, Maria Fernanda Lima Giuberti, Gabriel Carvalho Pereira, Taisa Risque Fernandes, Rosane Maria Falasco Bolzoni, Ana Carolina Jesus Vieira, Patrícia Vianna Bonini Palma, Anibal Basile, Jr., Fernando Chahud, Benedito Pina Almeida Prado, Jr., Maristela Delgado Orellana, Gil Cunha De Santis, Eduardo M Rego, Rodrigo T. Calado, Dimas T. Covas
Journal: Blood
Blood (2021) 138 (Supplement 1): 4843.
https://doi.org/10.1182/blood-2021-154217
Published: 2021
Journal Articles

Experience of Generic Imatinib As a First Line Therapy for Patients with Chronic Myeloid Leukemia in a Single Reference Institution

Gabriel Carvalho Pereira, MD, Fernanda B da Silva, BSc and MSc, Luisa Espirito Santo Oliveira, Pedro Marques Garibaldi, MD, Lorena Lobo Figueiredo-Pontes, MD PhD, Belinda Pinto Simões, MD PhD, Leonardo Carvalho Palma, MD PhD, Fabiola Traina, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5916.
https://doi.org/10.1182/blood-2019-132045
Published: 2019